Filing Flows › Kura Oncology (KURA) › Who owns the stock
Who owns Kura Oncology (KURA) stock
212 funds reported Kura Oncology (KURA) shares in their latest 13F filings, worth $1.0B in all. The largest holder is BlackRock ($115M). Last quarter 105 funds added to their stakes and 86 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 10,509,233 | $115M | increase | 2026-06-30 |
| Suvretta Capital Management, LLC | 8,575,422 | $94.1M | unchanged | 2026-06-30 |
| BVF | 8,445,769 | $92.7M | unchanged | 2026-06-30 |
| State Street | 5,329,208 | $58.5M | increase | 2026-06-30 |
| Vanguard Group | 5,507,627 | $57.2M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 3,916,164 | $43.0M | increase | 2026-06-30 |
| Armistice Capital, LLC | 3,678,000 | $40.3M | decrease | 2026-06-30 |
| AQR Capital Management LLC | 3,126,727 | $34.3M | increase | 2026-06-30 |
| Goldman Sachs Group | 2,265,171 | $24.8M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 2,229,958 | $24.5M | increase | 2026-06-30 |
| Alethea Capital Management, LLC | 2,167,938 | $23.8M | increase | 2026-06-30 |
| Prosight Management, LP | 2,021,964 | $22.2M | decrease | 2026-06-30 |
| Deep Track Capital, LP | 1,978,565 | $21.7M | decrease | 2026-06-30 |
| Renaissance Technologies LLC | 1,663,765 | $18.3M | increase | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 1,410,275 | $15.5M | new | 2026-06-30 |
Kura Oncology's latest quarter
Kura Oncology, Q2 2026: revenue $20.9M (+36% year over year), operating margin -349.8%, net loss $68.3M, operating cash flow −$62.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most KURA stock?
By the latest 13F filings: BlackRock ($115M); Suvretta Capital Management, LLC ($94.1M); BVF ($92.7M); State Street ($58.5M); Vanguard Group ($57.2M).
What is the short interest in KURA?
14,319,826 shares were sold short at the 2026-10-15 settlement, -0.69% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.